+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Topical Drug Delivery Market Analysis by Product, by Route of Administration, by Facility of Use, and by Region - Global Forecast to 2029

  • PDF Icon

    Report

  • 135 Pages
  • September 2022
  • Region: Global
  • Quintana Research and Consulting
  • ID: 5651494
The topical drug delivery market size is estimated to be USD 229.7 billion in 2021 and is expected to witness a CAGR of 11.51% during the forecast period 2022-2029. The high frequency of skin and soft tissue infections, rising prevalence of eye disorders and burns, are some of the key drivers for the market growth. Additionally, the rising funding from the government organizations pharmaceutical research and growing healthcare infrastructure in developing economies is projected to drive the market growth in near future. However, presence of alternate drug delivery mechanisms such as oral and injectable methods are expected to restrain the market growth.

By Product

Based on product, the market is categorized into solid formulations, semi-solid formulations, transdermal products, and liquid formulations. In 2021, the semi-solid formulations segment accounted for the highest revenue share owing to low density, higher stability under atmospheric conditions than liquid and solid forms, and growth in customised medicine due to their distinctive composition and improved absorptive qualities make them suitable for APIs.

By Route of Administration

On the basis of route of administration, the market is segregated into ophthalmic drug delivery, dermal drug delivery, nasal drug delivery, rectal drug delivery, and vaginal drug delivery. In 2021, the dermal drug delivery segment accounted for the highest revenue share due to the elimination of frequent drug delivery and the peaks and valleys in plasma levels associated with oral dosage and injections to maintain a constant drug concentration and benefits for medications with shorter half-lives or narrow therapeutic indices.

By Facility of Use

Based on facility of use, the market is categorized into hospitals and clinics, home care settings, burn centers, and other facilities. In 2021, the segment accounted for the highest revenue share owing to benefits for long-term therapy, improved convenience over inpatient care, and greater medical adherence and treatment results, worldwide rise in the number of elderly people, and increasing need for self-administration of medications.

Regional Markets

In 2021, Asia Pacific region accounted for the highest revenue in the topical drug delivery market and is expected to maintain its dominance during the forecast period. This is attributed to high prevalence of skin problems, rising contraceptive use, and pharmaceutical companies' increased focus on R&D of smart transdermal drug delivery systems.

Competitor Insights

Some of the key players operating in the topical drug delivery market are Johnson & Johnson (US), Nestlé SA (Switzerland), Novartis AG (Switzerland), GlaxoSmithKline (UK), Bausch Health Companies (Canada), Merck & Co (US), Bayer AG (Germany), Hisamitsu Pharmaceutical (Japan), Glenmark Pharmaceuticals (India), Cipla Ltd (India), Crescita Therapeutics Inc. (Canada), Mylan (US), Encore Dermatology, Inc. (US), LEO Pharma (Denmark), Almirall, S.A (Spain), Aclaris Therapeutics, Inc. (US), Taro Pharmaceutical Industries Ltd. (US), Teligent Pharma (US), Perrigo Pharma (US), Allergan (Ireland), Biofrontera, Inc. (US), Crown Laboratories Inc. (US), Akorn Inc. (US), Ingenus Pharmaceuticals (US), and Sun Pharmaceuticals (India).

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including product, route of administration, and facility of use from 2020 to 2029.

Segmentation: Topical Drug Delivery Market Report 2021-2029

Product (Revenue, USD Billion)

  • Solid Formulations
  • Semi-Solid Formulations
  • Transdermal Products
  • Liquid Formulations

By Route of Administration (Revenue, USD Billion)

  • Ophthalmic Drug Delivery
  • Dermal Drug Delivery
  • Nasal Drug Delivery
  • Rectal Drug Delivery
  • Vaginal Drug Delivery

By Facility of Use (Revenue, USD Billion)

  • Hospitals and Clinics
  • Home Care Settings
  • Burn Centres
  • Other Facilities

By Region (Revenue, USD Billion)

North America

  • U.S
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1.Study Objectives
1.2.Study Scope
1.3.Research Assumptions
1.4.Research Framework
1.4.1.Research Models
1.4.1.1.Bottom-up Approach
1.4.1.2.Top-down Approach
1.4.1.3.Data Triangulation
1.4.2.Data Procurement
1.4.2.1.Internal Database
1.4.2.2.Secondary Research
1.4.2.3.Purchased Database
1.4.2.4.Primary Research
1.4.3.Data Analysis
1.4.3.1.Data Validation
1.4.3.2.Market Size Estimation
1.4.3.3.Market Forecast Model
1.4.4.Quality Assessment
2. Introduction: Topical Drug Delivery
3. Executive Summary
3.1.Global Market Scenario
3.2.Segment Market Scenario
3.3.Geographic Market Scenario
3.4.COVID-19 Impact
3.5.Competitive Landscape
4. Market Dynamics
4.1.Market Drivers
4.1.1.Driver 1
4.1.2.Driver 2
4.1.3.Driver 3
4.1.4.Driver 4
4.1.5.Driver 5
4.2. Market Restraint
4.2.1.Restraint 1
4.2.2.Restraint 2
4.2.3.Restraint 3
4.2.4.Restraint 4
4.3.Market Opportunities
4.3.1.Opportunity 1
4.3.2.Opportunity 2
4.3.3.Opportunity 3
4.3.4.Opportunity 4
4.4.Market Trends
4.4.1.Trend 1
4.4.2.Trend 2
4.4.3.Trend 3
4.4.4.Trend 4
4.5.Market Challenges
4.5.1.Challenge 1
4.5.2.Challenge 2
4.5.3.Challenge 3
4.5.4.Challenge 4
5. Market Environment Analysis
5.1.Porter’s 5 Forces Analysis
5.2.PESTEL Analysis
5.3.Value Chain Analysis
5.4.SWOT Analysis
5.5.Benchmark
6. COVID-19 Impact Analysis: Topical Drug Delivery Market
6.1.COVID-19: Overview
6.2.COVID-19 Impact on the Global Market
6.3.COVID-19 Impact on the Regional Markets
7. Market Analysis by Product
7.1.Solid Formulations
7.1.1.Solid Formulations Market Forecast, 2021-2029 (USD Million)
7.2.Semi-Solid Formulations
7.2.1.Semi-Solid Formulations Market Forecast, 2021-2029 (USD Million)
7.3.Transdermal Products
7.3.1.Transdermal Products Market Forecast, 2021-2029 (USD Million)
7.4.Liquid Formulations
7.4.1.Liquid Formulations Market Forecast, 2021-2029 (USD Million)
8. Market Analysis by Route of Administration
8.1.Ophthalmic Drug Delivery
8.1.1.Ophthalmic Drug Delivery Market Forecast, 2021-2029 (USD Million)
8.2.Dermal Drug Delivery
8.2.1.Dermal Drug Delivery Market Forecast, 2021-2029 (USD Million)
8.3.Nasal Drug Delivery
8.3.1.Nasal Drug Delivery Market Forecast, 2021-2029 (USD Million)
8.4.Rectal Drug Delivery
8.4.1.Rectal Drug Delivery Market Forecast, 2021-2029 (USD Million)
8.5.Vaginal Drug Delivery
8.5.1.Vaginal Drug Delivery Market Forecast, 2021-2029 (USD Million)
9. Market Analysis by Facility of Use
9.1.Hospitals and Clinics
9.1.1.Hospitals and Clinics Market Forecast, 2021-2029 (USD Million)
9.2. Home Care Settings
9.2.1. Home Care Settings Market Forecast, 2021-2029 (USD Million)
9.3.Burn Centres
9.3.1.Burn Centres Market Forecast, 2021-2029 (USD Million)
9.4.Other Facilities
9.4.1.Other Facilities Market Forecast, 2021-2029 (USD Million)
10. Regional Market Analysis
10.1.Regional Market Trends
10.2.Regional Market: Comparative Analysis
11. North America Topical Drug Delivery Market
11.1.North America Topical Drug Delivery Market
11.1.1.North America Market Size and Forecast, 2021-2029 (USD Million)
11.1.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
11.1.1.2.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
11.1.1.3.Market Size and Forecast byFacility of Use, 2021-2029 (USD Million)
11.2.U.S. Topical Drug Delivery Market
11.2.1.U.S. Market Size and Forecast, 2021-2029 (USD Million)
11.2.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
11.2.1.2.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
11.2.1.3.Market Size and Forecast byFacility of Use, 2021-2029 (USD Million)
11.3.Canada Topical Drug Delivery Market
11.3.1.Canada Market Size and Forecast, 2021-2029 (USD Million)
11.3.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
11.3.1.2.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
11.3.1.3.Market Size and Forecast byFacility of Use, 2021-2029 (USD Million)
12. Europe Topical Drug Delivery Market
12.1.Europe Topical Drug Delivery Market
12.1.1.Europe Market Size and Forecast, 2021-2029 (USD Million)
12.1.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
12.1.1.2.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
12.1.1.3.Market Size and Forecast byFacility of Use, 2021-2029 (USD Million)
12.2.Germany Topical Drug Delivery Market
12.2.1.Germany Market Size and Forecast, 2021-2029 (USD Million)
12.2.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
12.2.1.2.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
12.2.1.3.Market Size and Forecast byFacility of Use, 2021-2029 (USD Million)
12.3.UK Topical Drug Delivery Market
12.3.1.UK Market Size and Forecast, 2021-2029 (USD Million)
12.3.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
12.3.1.2.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
12.3.1.3.Market Size and Forecast byFacility of Use, 2021-2029 (USD Million)
12.4.France Topical Drug Delivery Market
12.4.1.France Market Size and Forecast, 2021-2029 (USD Million)
12.4.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
12.4.1.2.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
12.4.1.3.Market Size and Forecast byFacility of Use, 2021-2029 (USD Million)
12.5.Spain Topical Drug Delivery Market
12.5.1.Spain Market Size and Forecast, 2021-2029 (USD Million)
12.5.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
12.5.1.2.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
12.5.1.3.Market Size and Forecast byFacility of Use, 2021-2029 (USD Million)
12.6.Italy Topical Drug Delivery Market
12.6.1.Italy Market Size and Forecast, 2021-2029 (USD Million)
12.6.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
12.6.1.2.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
12.6.1.3.Market Size and Forecast byFacility of Use, 2021-2029 (USD Million)
12.7.Rest of Europe Topical Drug Delivery Market
12.7.1.Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
12.7.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
12.7.1.2.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
12.7.1.3.Market Size and Forecast byFacility of Use, 2021-2029 (USD Million)
13. Asia Pacific Topical Drug Delivery Market
13.1.Asia Pacific Topical Drug Delivery Market
13.1.1.Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
13.1.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
13.1.1.2.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
13.1.1.3.Market Size and Forecast byFacility of Use, 2021-2029 (USD Million)
13.2.Japan Topical Drug Delivery Market
13.2.1.Japan Market Size and Forecast, 2021-2029 (USD Million)
13.2.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
13.2.1.2.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
13.2.1.3.Market Size and Forecast byFacility of Use, 2021-2029 (USD Million)
13.3.China Topical Drug Delivery Market
13.3.1.China Market Size and Forecast, 2021-2029 (USD Million)
13.3.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
13.3.1.2.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
13.3.1.3.Market Size and Forecast byFacility of Use, 2021-2029 (USD Million)
13.4.India Topical Drug Delivery Market
13.4.1.India Market Size and Forecast, 2021-2029 (USD Million)
13.4.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
13.4.1.2.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
13.4.1.3.Market Size and Forecast byFacility of Use, 2021-2029 (USD Million)
13.5.South Korea Topical Drug Delivery Market
13.5.1.South Korea Market Size and Forecast, 2021-2029 (USD Million)
13.5.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
13.5.1.2.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
13.5.1.3.Market Size and Forecast byFacility of Use, 2021-2029 (USD Million)
13.6.Australia Topical Drug Delivery Market
13.6.1.Australia Market Size and Forecast, 2021-2029 (USD Million)
13.6.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
13.6.1.2.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
13.6.1.3.Market Size and Forecast byFacility of Use, 2021-2029 (USD Million)
13.7.Rest of Asia Pacific Topical Drug Delivery Market
13.7.1.Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
13.7.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
13.7.1.2.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
13.7.1.3.Market Size and Forecast byFacility of Use, 2021-2029 (USD Million)
14. Latin America Topical Drug Delivery Market
14.1.Latin America Topical Drug Delivery Market
14.1.1.Latin America Market Size and Forecast, 2021-2029 (USD Million)
14.1.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
14.1.1.2.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
14.1.1.3.Market Size and Forecast byFacility of Use, 2021-2029 (USD Million)
14.2.Brazil Topical Drug Delivery Market
14.2.1.Brazil Market Size and Forecast, 2021-2029 (USD Million)
14.2.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
14.2.1.2.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
14.2.1.3.Market Size and Forecast byFacility of Use, 2021-2029 (USD Million)
14.3.Mexico Topical Drug Delivery Market
14.3.1.Mexico Market Size and Forecast, 2021-2029 (USD Million)
14.3.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
14.3.1.2.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
14.3.1.3.Market Size and Forecast byFacility of Use, 2021-2029 (USD Million)
14.4.Argentina Topical Drug Delivery Market
14.4.1.Argentina Market Size and Forecast, 2021-2029 (USD Million)
14.4.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
14.4.1.2.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
14.4.1.3.Market Size and Forecast byFacility of Use, 2021-2029 (USD Million)
14.5.Rest of Latin America Topical Drug Delivery Market
14.5.1.Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
14.5.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
14.5.1.2.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
14.5.1.3.Market Size and Forecast byFacility of Use, 2021-2029 (USD Million)
15. MEA Topical Drug Delivery Market
15.1.MEA Topical Drug Delivery Market
15.1.1.MEA Market Size and Forecast, 2021-2029 (USD Million)
15.1.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
15.1.1.2.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
15.1.1.3.Market Size and Forecast byFacility of Use, 2021-2029 (USD Million)
15.2.GCC Topical Drug Delivery Market
15.2.1.GCC Market Size and Forecast, 2021-2029 (USD Million)
15.2.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
15.2.1.2.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
15.2.1.3.Market Size and Forecast byFacility of Use, 2021-2029 (USD Million)
15.3.South Africa Topical Drug Delivery Market
15.3.1.South Africa Market Size and Forecast, 2021-2029 (USD Million)
15.3.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
15.3.1.2.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
15.3.1.3.Market Size and Forecast byFacility of Use, 2021-2029 (USD Million)
15.4.Rest of MEA Topical Drug Delivery Market
15.4.1.Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
15.4.1.1.Market Size and Forecast by Product, 2021-2029 (USD Million)
15.4.1.2.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
15.4.1.3.Market Size and Forecast byFacility of Use, 2021-2029 (USD Million)
16. Competitor Analysis
16.1.Market Share Analysis, 2021 & 2029
16.2.Competitive Mapping
16.3.Key Players Market Place Analysis
16.4.Major Recent Developments
17. Company Profiles
17.1.Johnson & Johnson (US)
17.1.1.Company Snapshot
17.1.2.Company Overview
17.1.3.Financials
17.1.4.Route of Administration Benchmarking
17.1.5.Recent Developments
17.2.Nestlé SA (Switzerland)
17.2.1.Company Snapshot
17.2.2.Company Overview
17.2.3.Financials
17.2.4.Route of Administration Benchmarking
17.2.5.Recent Developments
17.3.Novartis AG (Switzerland)
17.3.1.Company Snapshot
17.3.2.Company Overview
17.3.3.Financials
17.3.4.Route of Administration Benchmarking
17.3.5.Recent Developments
17.4.GlaxoSmithKline (UK)
17.4.1.Company Snapshot
17.4.2.Company Overview
17.4.3.Financials
17.4.4.Route of Administration Benchmarking
17.4.5.Recent Developments
17.5. Bausch Health Companies (Canada),
17.5.1.Company Snapshot
17.5.2.Company Overview
17.5.3.Financials
17.5.4.Route of Administration Benchmarking
17.5.5.Recent Developments
17.6.Merck & Co (US)
17.6.1.Company Snapshot
17.6.2.Company Overview
17.6.3.Financials
17.6.4.Route of Administration Benchmarking
17.6.5.Recent Developments
17.7. Bayer AG (Germany)
17.7.1.Company Snapshot
17.7.2.Company Overview
17.7.3.Financials
17.7.4.Route of Administration Benchmarking
17.7.5.Recent Developments
17.8.Hisamitsu Pharmaceutical (Japan)
17.8.1.Company Snapshot
17.8.2.Company Overview
17.8.3.Financials
17.8.4.Route of Administration Benchmarking
17.8.5.Recent Developments
17.9.Glenmark Pharmaceuticals (India)
17.9.1.Company Snapshot
17.9.2.Company Overview
17.9.3.Financials
17.9.4.Route of Administration Benchmarking
17.9.5.Recent Developments
17.10.Cipla Ltd (India)
17.10.1.Company Snapshot
17.10.2.Company Overview
17.10.3.Financials
17.10.4.Route of Administration Benchmarking
17.10.5.Recent Developments
17.11.Crescita Therapeutics Inc. (Canada)
17.11.1.Company Snapshot
17.11.2.Company Overview
17.11.3.Financials
17.11.4.Product Benchmarking
17.11.5.Recent Developments
17.12.Mylan (US)
17.12.1.Company Snapshot
17.12.2.Company Overview
17.12.3.Financials
17.12.4.Product Benchmarking
17.12.5.Recent Developments
17.13.Encore Dermatology, Inc. (US)
17.13.1.Company Snapshot
17.13.2.Company Overview
17.13.3.Financials
17.13.4.Product Benchmarking
17.13.5.Recent Developments
17.14.LEO Pharma (Denmark)
17.14.1.Company Snapshot
17.14.2.Company Overview
17.14.3.Financials
17.14.4.Product Benchmarking
17.14.5.Recent Developments
17.15.Almirall, S.A (Spain)
17.15.1.Company Snapshot
17.15.2.Company Overview
17.15.3.Financials
17.15.4.Product Benchmarking
17.15.5.Recent Developments
17.16.Others Prominent Players
18. Conclusion & Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Johnson & Johnson (US)
  • Nestlé SA (Switzerland)
  • Novartis AG (Switzerland)
  • GlaxoSmithKline (UK)
  • Bausch Health Companies (Canada)
  • Merck & Co (US)
  • Bayer AG (Germany)
  • Hisamitsu Pharmaceutical (Japan)
  • Glenmark Pharmaceuticals (India)
  • Cipla Ltd (India)
  • Crescita Therapeutics Inc. (Canada)
  • Mylan (US)
  • Encore Dermatology Inc. (US)
  • LEO Pharma (Denmark)
  • Almirall
  • S.A (Spain)
  • Aclaris Therapeutics Inc. (US)
  • Taro Pharmaceutical Industries Ltd. (US)
  • Teligent Pharma (US)
  • Perrigo Pharma (US)
  • Allergan (Ireland)
  • Biofrontera Inc. (US)
  • Crown Laboratories Inc. (US)
  • Akorn Inc. (US)
  • Ingenus Pharmaceuticals (US)
  • Sun Pharmaceuticals (India).